ST. PAUL, Minn.--(BUSINESS WIRE)-- Spineology Inc.,the innovator in anatomy-conserving spine surgery, announced today that it has received FDA clearance for, and is initiating launch of, the new Rampart™ line of Interbody fusion implants.
The Rampart line will include a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs. The Rampart System is further configured with implantation equipment designed to enhance the surgeon’s ability to position the implant within the disc space.
“Spineology is committed to developing the implant solutions our customers desire,” said John Booth, CEO for Spineology. “Rampart is a great synergistic fit for our growing product line.”
About Spineology Inc.
Spineology Inc., the innovator in anatomy-conserving spine surgery, develops spinal implants and instruments. Spineology surgical techniques conserve spinal bone, ligament and muscle tissue. Spineology is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery. Learn more at spineology.com.
Spineology Inc.John Booth, firstname.lastname@example.orgRisdall McKinney Public RelationsAndrea Goodall, email@example.com